Compare NBP & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBP | SDHY |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 403.2M |
| IPO Year | N/A | N/A |
| Metric | NBP | SDHY |
|---|---|---|
| Price | $3.11 | $16.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 432.4K | 76.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.52 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $15.01 |
| 52 Week High | $5.19 | $17.18 |
| Indicator | NBP | SDHY |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 43.96 |
| Support Level | $3.04 | $16.48 |
| Resistance Level | $3.74 | $16.62 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 17.78 | 35.34 |
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.